Suzhou Jingye Medicine & Chemical Co., Ltd., a national high-tech enterprise, is located in the Suzhou High-tech Industrial Development Zone, about 100 kilometers away from Shanghai. The company was established in the incubator of Suzhou High-tech Zone in 1998, mainly producing pharmaceutical raw materials, pharmaceutical intermediates and CDMO project services.

Suzhou Jingye Medicine & Chemical covers an area of nearly 80 mu. At present, it has 282 employees and 9 commercial production workshops, including 3 GMP workshops and 1 CDMO workshop. Main products include meglumine, trimetazidine hydrochloride, intermediate of quetiapine fumarate, intermediate of paroxetine hydrochloride, intermediate of nateglinide, etc; The customers are mainly domestic and foreign pharmaceutical enterprises, such as AstraZeneca, Sanofi, Sumitomo, Ajinomoto, TEVA, Slovenia KRKA, South Korea JW Pharmaceutical, Hengrui Pharmaceutical, Hausen Pharmaceutical, Fosun Pharmaceutical, Huahai Pharmaceutical, Qilu Pharmaceutical, Suber Pharmaceutical, Jiangsu Wuzhong Pharmaceutical and other famous pharmaceutical enterprises at home and abroad.

In 2008, the company passed ISO9001 quality management system certification, ISO14001 environmental management system certification and ISO18001 occupational health and safety management system certification for the first time; In 2014, it obtained the second-level certification of safety standardization in Jiangsu Province; In 2021, it obtained the drug production license.

So far, the company has 36 high-tech products, applied for 25 invention patents, and authorized 15 patents. In 2021, the sales of Suzhou Jingye Medicine & Chemical will be nearly 300 million yuan.

In order to speed up the development of the enterprise, the company purchased 100 mu of land in Jiangsu Huai'an Chemical Industry Park at the end of 2013. Huai'an Factory-Jiangsu Jiye Pharmaceutical Chemical Co., Ltd.(Jiangsu Haixin Medicine & Chemical Co.,Ltd.)  began to gradually put three special workshops into production in September 2016. In 2021, the sales of Jiangsu Jiye Pharmaceutical Chemical Co., Ltd.(Jiangsu Haixin Medicine & Chemical Co.,Ltd.)  was nearly 200 million yuan, and the new workshops and projects were being gradually improved.

We will, as always, be market-oriented, rely on scientific research and innovation, give full play to our own advantages, wholeheartedly provide more high-quality products and services to customers at home and abroad, and are willing to seek common development and win-win cooperation with friends from all walks of life.